S 239061
Alternative Names: S 23906; S 23906-1Latest Information Update: 19 Apr 2010
At a glance
- Originator Servier
- Class Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer